Ali Kemal Topaloglu, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hypogonadism | 22 | 2023 | 752 | 7.500 |
Why?
|
Kallmann Syndrome | 6 | 2022 | 140 | 2.430 |
Why?
|
Neurokinin B | 7 | 2021 | 67 | 2.390 |
Why?
|
Receptors, Neurokinin-3 | 5 | 2012 | 54 | 1.560 |
Why?
|
Gonadotropin-Releasing Hormone | 10 | 2023 | 1205 | 1.420 |
Why?
|
Puberty, Delayed | 5 | 2016 | 115 | 1.200 |
Why?
|
Nerve Tissue Proteins | 7 | 2022 | 4463 | 1.170 |
Why?
|
POU Domain Factors | 1 | 2023 | 46 | 0.920 |
Why?
|
Mutation, Missense | 7 | 2023 | 2566 | 0.860 |
Why?
|
Receptors, Cell Surface | 3 | 2022 | 2865 | 0.860 |
Why?
|
Pedigree | 14 | 2022 | 4643 | 0.800 |
Why?
|
Mutation | 19 | 2022 | 29777 | 0.800 |
Why?
|
Semaphorins | 1 | 2021 | 101 | 0.740 |
Why?
|
Reproduction | 4 | 2022 | 666 | 0.730 |
Why?
|
Receptors, LHRH | 2 | 2012 | 160 | 0.690 |
Why?
|
Puberty | 3 | 2012 | 490 | 0.690 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2022 | 1114 | 0.540 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2016 | 250 | 0.520 |
Why?
|
Gonadotropins | 1 | 2015 | 240 | 0.500 |
Why?
|
Phospholipases | 1 | 2014 | 72 | 0.500 |
Why?
|
Family Health | 3 | 2016 | 1280 | 0.480 |
Why?
|
Codon, Nonsense | 1 | 2014 | 281 | 0.450 |
Why?
|
Cerebellar Ataxia | 1 | 2014 | 145 | 0.440 |
Why?
|
eIF-2 Kinase | 2 | 2010 | 151 | 0.400 |
Why?
|
Protein Precursors | 1 | 2015 | 1154 | 0.390 |
Why?
|
Osteochondrodysplasias | 2 | 2010 | 182 | 0.380 |
Why?
|
Phenotype | 6 | 2022 | 16361 | 0.370 |
Why?
|
Amenorrhea | 2 | 2014 | 485 | 0.360 |
Why?
|
Neurosecretory Systems | 1 | 2011 | 231 | 0.360 |
Why?
|
Receptors, G-Protein-Coupled | 2 | 2014 | 1222 | 0.350 |
Why?
|
Nerve Degeneration | 1 | 2014 | 748 | 0.350 |
Why?
|
Substance P | 1 | 2009 | 335 | 0.320 |
Why?
|
Genetic Predisposition to Disease | 2 | 2018 | 17439 | 0.270 |
Why?
|
Adolescent | 18 | 2022 | 85729 | 0.260 |
Why?
|
Point Mutation | 1 | 2010 | 1623 | 0.240 |
Why?
|
Glutathione Synthase | 1 | 2004 | 3 | 0.240 |
Why?
|
Sexual Maturation | 2 | 2016 | 265 | 0.240 |
Why?
|
Acidosis, Lactic | 1 | 2005 | 142 | 0.230 |
Why?
|
DNA Mutational Analysis | 6 | 2016 | 4183 | 0.230 |
Why?
|
Diabetic Ketoacidosis | 1 | 2005 | 247 | 0.200 |
Why?
|
Metabolism, Inborn Errors | 1 | 2004 | 288 | 0.200 |
Why?
|
Tachykinins | 2 | 2012 | 78 | 0.190 |
Why?
|
Young Adult | 10 | 2022 | 56392 | 0.190 |
Why?
|
Homocystinuria | 1 | 2001 | 67 | 0.190 |
Why?
|
Homozygote | 4 | 2015 | 1787 | 0.190 |
Why?
|
Humans | 39 | 2023 | 743811 | 0.180 |
Why?
|
Tumor Suppressor Proteins | 3 | 2021 | 2850 | 0.180 |
Why?
|
Male | 25 | 2022 | 349776 | 0.180 |
Why?
|
alpha-Galactosidase | 1 | 1999 | 56 | 0.180 |
Why?
|
Genotype | 4 | 2018 | 12944 | 0.180 |
Why?
|
Mutant Proteins | 1 | 2022 | 500 | 0.180 |
Why?
|
Obesity | 1 | 2022 | 12744 | 0.170 |
Why?
|
Turkey | 2 | 2012 | 237 | 0.170 |
Why?
|
Dwarfism | 2 | 2014 | 145 | 0.170 |
Why?
|
Appetite | 1 | 2001 | 244 | 0.170 |
Why?
|
Fabry Disease | 1 | 1999 | 89 | 0.170 |
Why?
|
Hypothalamo-Hypophyseal System | 2 | 2014 | 703 | 0.160 |
Why?
|
Brain | 2 | 2023 | 26345 | 0.160 |
Why?
|
Female | 25 | 2022 | 380020 | 0.160 |
Why?
|
Homocysteine | 1 | 2001 | 647 | 0.150 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2010 | 3338 | 0.150 |
Why?
|
Metabolic Networks and Pathways | 1 | 2022 | 783 | 0.150 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2001 | 364 | 0.150 |
Why?
|
DNA-Binding Proteins | 1 | 2014 | 9648 | 0.150 |
Why?
|
Peptide Fragments | 1 | 2009 | 5096 | 0.140 |
Why?
|
Klinefelter Syndrome | 1 | 2016 | 49 | 0.140 |
Why?
|
Genetic Association Studies | 2 | 2018 | 2703 | 0.140 |
Why?
|
Neurons | 4 | 2022 | 9336 | 0.140 |
Why?
|
Animals | 10 | 2023 | 168660 | 0.140 |
Why?
|
Mammals | 1 | 2021 | 1143 | 0.140 |
Why?
|
Heterozygote | 1 | 2022 | 2803 | 0.130 |
Why?
|
Mice | 6 | 2023 | 81154 | 0.130 |
Why?
|
Transcriptional Activation | 1 | 2022 | 1783 | 0.130 |
Why?
|
Consanguinity | 3 | 2014 | 455 | 0.130 |
Why?
|
Sequence Analysis, DNA | 3 | 2017 | 4803 | 0.130 |
Why?
|
Adult | 14 | 2022 | 213889 | 0.130 |
Why?
|
Body Height | 1 | 2001 | 1579 | 0.120 |
Why?
|
Amino Acid Sequence | 2 | 2022 | 13809 | 0.120 |
Why?
|
Ligands | 1 | 2021 | 3281 | 0.120 |
Why?
|
Mouth Abnormalities | 1 | 2014 | 19 | 0.120 |
Why?
|
Transcription Factors | 1 | 2014 | 12209 | 0.120 |
Why?
|
Cell Adhesion Molecules | 1 | 2021 | 1602 | 0.120 |
Why?
|
Bone and Bones | 1 | 2005 | 2576 | 0.120 |
Why?
|
Carboxylic Ester Hydrolases | 1 | 2014 | 98 | 0.120 |
Why?
|
Gelatinases | 1 | 2014 | 94 | 0.120 |
Why?
|
Tooth Abnormalities | 1 | 2014 | 54 | 0.120 |
Why?
|
Primary Ovarian Insufficiency | 1 | 2014 | 115 | 0.120 |
Why?
|
Olfactory Receptor Neurons | 1 | 2014 | 92 | 0.120 |
Why?
|
Protein Conformation | 1 | 2022 | 4009 | 0.120 |
Why?
|
Chromosomal Instability | 1 | 2014 | 183 | 0.120 |
Why?
|
Leptin | 1 | 2001 | 1600 | 0.110 |
Why?
|
Iron | 1 | 2001 | 1774 | 0.110 |
Why?
|
Genes, Recessive | 3 | 2012 | 641 | 0.110 |
Why?
|
Calcium | 2 | 2005 | 5755 | 0.110 |
Why?
|
Hypothyroidism | 2 | 2010 | 659 | 0.110 |
Why?
|
Fatal Outcome | 2 | 2010 | 1851 | 0.100 |
Why?
|
Acidosis | 2 | 2004 | 271 | 0.100 |
Why?
|
Models, Molecular | 1 | 2022 | 5445 | 0.100 |
Why?
|
HEK293 Cells | 1 | 2021 | 4204 | 0.100 |
Why?
|
Cohort Studies | 4 | 2021 | 40545 | 0.100 |
Why?
|
Family | 2 | 2014 | 3144 | 0.090 |
Why?
|
Membrane Proteins | 2 | 2021 | 7880 | 0.090 |
Why?
|
Phospholipids | 1 | 2014 | 784 | 0.090 |
Why?
|
Receptors, Tachykinin | 1 | 2010 | 25 | 0.090 |
Why?
|
Promoter Regions, Genetic | 1 | 2022 | 5867 | 0.090 |
Why?
|
Pancreas, Exocrine | 1 | 2010 | 45 | 0.090 |
Why?
|
Deafness | 1 | 2014 | 458 | 0.090 |
Why?
|
Epiphyses | 1 | 2010 | 189 | 0.080 |
Why?
|
Gonads | 1 | 2008 | 109 | 0.080 |
Why?
|
Histidine | 1 | 2009 | 312 | 0.080 |
Why?
|
Hydroxyproline | 2 | 2005 | 116 | 0.080 |
Why?
|
Serine Endopeptidases | 1 | 2014 | 1073 | 0.080 |
Why?
|
Leucine | 1 | 2009 | 559 | 0.080 |
Why?
|
COS Cells | 2 | 2006 | 1161 | 0.080 |
Why?
|
Liver Failure | 1 | 2010 | 241 | 0.080 |
Why?
|
Infant | 7 | 2012 | 35122 | 0.080 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2008 | 374 | 0.080 |
Why?
|
Osteocalcin | 2 | 2005 | 273 | 0.080 |
Why?
|
Alleles | 1 | 2018 | 6934 | 0.080 |
Why?
|
Gonadal Dysgenesis, 46,XX | 1 | 2006 | 5 | 0.070 |
Why?
|
Gonadal Dysgenesis, 46,XY | 1 | 2006 | 11 | 0.070 |
Why?
|
Protein Isoforms | 1 | 2012 | 1729 | 0.070 |
Why?
|
Pituitary-Adrenal System | 1 | 2010 | 553 | 0.070 |
Why?
|
Steroid 17-alpha-Hydroxylase | 1 | 2006 | 98 | 0.070 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2016 | 15518 | 0.070 |
Why?
|
Computational Biology | 1 | 2018 | 3515 | 0.070 |
Why?
|
Genetic Variation | 1 | 2022 | 6535 | 0.070 |
Why?
|
Axons | 1 | 2014 | 1685 | 0.070 |
Why?
|
Hormones | 1 | 2009 | 889 | 0.070 |
Why?
|
Siblings | 1 | 2009 | 853 | 0.060 |
Why?
|
Alkaline Phosphatase | 2 | 2005 | 866 | 0.060 |
Why?
|
Thyrotropin, beta Subunit | 1 | 2004 | 4 | 0.060 |
Why?
|
Neutropenia | 1 | 2010 | 895 | 0.060 |
Why?
|
Congenital Hypothyroidism | 1 | 2004 | 39 | 0.060 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2008 | 2839 | 0.060 |
Why?
|
Child | 9 | 2014 | 77637 | 0.060 |
Why?
|
Founder Effect | 1 | 2004 | 189 | 0.060 |
Why?
|
Pyrrolidonecarboxylic Acid | 1 | 2004 | 65 | 0.060 |
Why?
|
Cell Movement | 1 | 2016 | 5216 | 0.060 |
Why?
|
Dehydration | 1 | 2005 | 232 | 0.060 |
Why?
|
Lacrimal Apparatus Diseases | 1 | 2003 | 65 | 0.060 |
Why?
|
Creatine | 1 | 2005 | 421 | 0.060 |
Why?
|
Homeostasis | 1 | 2014 | 3337 | 0.060 |
Why?
|
Repressor Proteins | 1 | 2014 | 3024 | 0.060 |
Why?
|
Esophageal Achalasia | 1 | 2003 | 90 | 0.050 |
Why?
|
Carrier Proteins | 1 | 2016 | 5021 | 0.050 |
Why?
|
Gastroenteritis | 1 | 2004 | 245 | 0.050 |
Why?
|
Cell Membrane | 2 | 2014 | 3749 | 0.050 |
Why?
|
Homocystine | 1 | 2001 | 22 | 0.050 |
Why?
|
Prevalence | 1 | 2018 | 15211 | 0.050 |
Why?
|
Adrenal Insufficiency | 1 | 2003 | 184 | 0.050 |
Why?
|
Transfection | 2 | 2006 | 5892 | 0.050 |
Why?
|
Introns | 2 | 2004 | 991 | 0.050 |
Why?
|
Genetic Heterogeneity | 1 | 2004 | 733 | 0.050 |
Why?
|
Base Sequence | 2 | 2014 | 12798 | 0.050 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2005 | 2556 | 0.050 |
Why?
|
Breast | 1 | 2009 | 1970 | 0.050 |
Why?
|
Bone Diseases, Metabolic | 1 | 2004 | 417 | 0.050 |
Why?
|
Statistics, Nonparametric | 1 | 2005 | 2883 | 0.040 |
Why?
|
Growth | 1 | 2001 | 376 | 0.040 |
Why?
|
Lipid Metabolism, Inborn Errors | 1 | 1999 | 122 | 0.040 |
Why?
|
Growth Substances | 1 | 2001 | 784 | 0.040 |
Why?
|
Prospective Studies | 2 | 2014 | 53250 | 0.040 |
Why?
|
Molecular Sequence Data | 2 | 2014 | 18107 | 0.040 |
Why?
|
Ferritins | 1 | 2001 | 590 | 0.040 |
Why?
|
Exons | 2 | 2003 | 2438 | 0.040 |
Why?
|
Blotting, Western | 2 | 2016 | 5179 | 0.040 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2005 | 2017 | 0.040 |
Why?
|
Child, Preschool | 6 | 2005 | 40964 | 0.040 |
Why?
|
X Chromosome | 1 | 1999 | 814 | 0.030 |
Why?
|
Regression Analysis | 1 | 2005 | 6457 | 0.030 |
Why?
|
Alternative Splicing | 1 | 1999 | 1117 | 0.030 |
Why?
|
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2014 | 88 | 0.030 |
Why?
|
RNA Splice Sites | 1 | 2014 | 209 | 0.030 |
Why?
|
Middle Aged | 3 | 2017 | 213241 | 0.030 |
Why?
|
Subcellular Fractions | 1 | 2014 | 545 | 0.030 |
Why?
|
Genetic Markers | 1 | 1999 | 2634 | 0.030 |
Why?
|
Models, Biological | 1 | 2008 | 9582 | 0.030 |
Why?
|
Bone Density | 1 | 2004 | 3460 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 1999 | 4737 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2014 | 1799 | 0.020 |
Why?
|
Blood Glucose | 1 | 2005 | 6259 | 0.020 |
Why?
|
Signal Transduction | 2 | 2014 | 23398 | 0.020 |
Why?
|
Endopeptidases | 1 | 2014 | 772 | 0.020 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2014 | 594 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2014 | 1793 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2016 | 2692 | 0.020 |
Why?
|
Dietary Supplements | 1 | 2001 | 3292 | 0.020 |
Why?
|
Proteins | 1 | 2003 | 6098 | 0.020 |
Why?
|
Syndrome | 2 | 2004 | 3249 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2016 | 3917 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2004 | 25609 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 4749 | 0.020 |
Why?
|
DNA Repair | 1 | 2014 | 2045 | 0.020 |
Why?
|
Body Mass Index | 1 | 2001 | 12718 | 0.010 |
Why?
|
Fibroblasts | 1 | 2014 | 4162 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2014 | 5973 | 0.010 |
Why?
|
Guanine | 1 | 2004 | 274 | 0.010 |
Why?
|
Nuclear Pore Complex Proteins | 1 | 2003 | 165 | 0.010 |
Why?
|
Genes, Reporter | 1 | 2006 | 1545 | 0.010 |
Why?
|
Progesterone | 1 | 2006 | 773 | 0.010 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2003 | 462 | 0.010 |
Why?
|
Collagen Type I | 1 | 2004 | 592 | 0.010 |
Why?
|
Magnesium | 1 | 2004 | 813 | 0.010 |
Why?
|
Thyrotropin | 1 | 2004 | 850 | 0.010 |
Why?
|
Skin | 1 | 2014 | 4372 | 0.010 |
Why?
|
Cell Line | 1 | 2014 | 15993 | 0.010 |
Why?
|
Adenine | 1 | 2004 | 935 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2014 | 13028 | 0.010 |
Why?
|
Creatinine | 1 | 2004 | 1918 | 0.010 |
Why?
|
Osteoblasts | 1 | 2004 | 1164 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2014 | 19232 | 0.010 |
Why?
|
Haplotypes | 1 | 2004 | 2779 | 0.010 |
Why?
|
Apoptosis | 1 | 2014 | 9718 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2014 | 21733 | 0.010 |
Why?
|
Radiography | 1 | 2006 | 7010 | 0.010 |
Why?
|
Acute Disease | 1 | 2004 | 7150 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2001 | 77410 | 0.010 |
Why?
|
Blood Pressure | 1 | 2006 | 8551 | 0.010 |
Why?
|